Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, Daniel, Wang, Nianshuang, Corbett, Kizzmekia S., Goldsmith, Jory A., Hsieh, Ching-Lin, Abiona, Olubukola, Graham, Barney S., McLellan, Jason S.·2020·Science
DOI 10.1126/science.abb2507

Cited by (1,048)

Items 301–400 of 1,048

  1. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
    S. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Victoria Stalls, Megan Kopp, Kartik Manne, Dapeng Li, Kevin J. Wiehe et al. · 2021 · Science
  2. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
    Paul-Albert Koenig, Hrishikesh Das, Hejun Liu, Beate Mareike Kümmerer, Florian N. Gohr, Lea‐Marie Jenster, Lisa D. J. Schiffelers, Yonas M. Tesfamariam, Miki Uchima, Jennifer Deborah Wuerth et al. · 2021 · Science
  3. The antigenic anatomy of SARS-CoV-2 receptor binding domain
    Dejnirattisai, Wanwisa, Zhou, Daming, Ginn, Helen M., Duyvesteyn, Helen M.E., Supasa, Piyada, Case, James Brett, Zhao, Yuguang, Walter, Thomas S., Mentzer, Alexander J., Liu, Chang et al. · 2021 · Cell
  4. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
    Yasunori Watanabe, Zachary T. Berndsen, Jayna Raghwani, Gemma E. Seabright, Joel D. Allen, Oliver G. Pybus, Jason S. McLellan, Ian A. Wilson, Thomas A. Bowden, Andrew B. Ward et al. · 2020 · Nature Communications
  5. Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
    Fabián Sanchis‐Gomar, Carl J. Lavie, Mandeep R. Mehra, Brandon Michael Henry, Giuseppe Lippi · 2020 · Mayo Clinic Proceedings
  6. A glycan gate controls opening of the SARS-CoV-2 spike protein
    Terra Sztain, Surl-Hee Ahn, Anthony T. Bogetti, Lorenzo Casalino, Jory A. Goldsmith, Evan E. Seitz, Ryan S. McCool, Fiona L. Kearns, F.J. Acosta-Reyes, Suvrajit Maji et al. · 2021 · Nature Chemistry
  7. Molecular diagnostic technologies for COVID-19: Limitations and challenges
    Adeel Afzal · 2020 · Journal of Advanced Research
  8. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
    Seydoux, Emilie, Homad, Leah J., MacCamy, Anna J., Parks, K. Rachael, Hurlburt, Nicholas K., Jennewein, Madeleine F., Akins, Nicholas R., Stuart, Andrew B., Wan, Yu-Hsin, Feng, Junli et al. · 2020 · Immunity
  9. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
    Zhe Lv, Yong‐Qiang Deng, Qing Ye, Lei Cao, Chun-Yun Sun, Changfa Fan, Weijin Huang, Shihui Sun, Yao Sun, Ling Zhu et al. · 2020 · Science
  10. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
    Brian J. Ward, Philipe Gobeil, Annie Séguin, Judith Atkins, Iohann Boulay, Pierre-Yves Charbonneau, Manon Couture, Marc‐André D’Aoust, Jiwanjeet K. Dhaliwall, Carolyn D. Finkle et al. · 2021 · Nature Medicine
  11. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
    Franz Xaver Heinz, Karin Stiasny · 2021 · npj Vaccines
  12. COVID-19, diabetes mellitus and ACE2: The conundrum
    Rimesh Pal, Anil Kumar Bhansali · 2020 · Diabetes Research and Clinical Practice
  13. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
    Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, Uma Maheswari Krishnan · 2020 · Biochimie
  14. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
    Wheatley, Adam K., Juno, Jennifer A., Wang, Jing J., Selva, Kevin J., Reynaldi, Arnold, Tan, Hyon-Xhi, Lee, Wen Shi, Wragg, Kathleen M., Kelly, Hannah G., Esterbauer, Robyn et al. · 2021 · Nature Communications
  15. Structural insights into SARS-CoV-2 proteins
    Rimanshee Arya, Shweta Kumari, Bharati Pandey, Hiral Mistry, Subhash Chandra Bihani, Amit Das, Vishal Prashar, Gagan D. Gupta, Lata Panicker, Mukesh Kumar · 2020 · Journal of Molecular Biology
  16. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
    2020 · npj Vaccines
  17. A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2
    Cassandra L. Atzrodt, Insha H. Maknojia, Robert D. P. McCarthy, Tiara M. Oldfield, Jonathan Po, Kenny T. L. Ta, Hannah E. Stepp, Thomas P. Clements · 2020 · FEBS Journal
  18. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
    Carly G.K. Ziegler, Vincent N. Miao, Anna H. Owings, Andrew W. Navia, Ying Tang, Joshua D. Bromley, Peter Lotfy, Meredith Sloan, Hannah Laird, Haley B. Williams et al. · 2021 · Cell
  19. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
    So Young Kim, Weihua Jin, Amika Sood, David W. Montgomery, Oliver C. Grant, Mark M. Fuster, Li Fu, Jonathan S. Dordick, Robert J. Woods, Fuming Zhang et al. · 2020 · Antiviral Research
  20. TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
    Jana Koch, Zina M. Uckeley, Patricio Doldan, Megan Lynn Stanifer, Steeve Boulant, Pierre‐Yves Lozach · 2021 · The EMBO Journal
  21. Pathophysiology of COVID-19: Why Children Fare Better than Adults?
    Nitin Dhochak, Tanu Singhal, Sushil Kumar Kabra, Rakesh Lodha · 2020 · The Indian Journal of Pediatrics
  22. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension
    Guang Yang, Zihu Tan, Ling Zhou, Min Hee Yang, Lang Peng, Jinjin Liu, Jingling Cai, Ru Yang, Junyan Han, Yafei Huang et al. · 2020 · Hypertension
  23. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
    Young Hun Chung, Veronique Beiss, Steven Fiering, Nicole F. Steinmetz · 2020 · ACS Nano
  24. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
    Tongqing Zhou, Yaroslav Tsybovsky, Jason Gorman, Micah Rapp, Gabriele Cerutti, Gwo‐Yu Chuang, Phinikoula S. Katsamba, Jared M. Sampson, Arne Schön, Jude Saber Bimela et al. · 2020 · Cell Host & Microbe
  25. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
    Qianqian Zhang, Rong Xiang, Shanshan Huo, Yunjiao Zhou, Shibo Jiang, Qiao Wang, Fei Yu · 2021 · Signal Transduction and Targeted Therapy
  26. IL-6: Relevance for immunopathology of SARS-CoV-2
    Ekaterina O. Gubernatorova, Ekaterina A. Gorshkova, Almina I. Polinova, Marina S. Drutskaya · 2020 · Cytokine & Growth Factor Reviews
  27. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
    Yanwen Liang, Mong‐Lien Wang, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, Yi-Ping Yang, Wei-Yi Lai, Yung‐Hung Luo, Yi-Tsung Lin, Yann-Jang Chen, Pei‐Ching Chang et al. · 2020 · Frontiers in Immunology
  28. Nucleic acid delivery for therapeutic applications
    Akash Gupta, Jason L. Andresen, Rajith S. Manan, Róbert Langer · 2021 · Advanced Drug Delivery Reviews
  29. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
    Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen et al. · 2021 · Cell
  30. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
    Michael I. Barton, Stuart A. MacGowan, Mikhail A. Kutuzov, Omer Dushek, Geoffrey J. Barton, P. Anton van der Merwe · 2021 · eLife
  31. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
    Mark Andrew Ainsworth, Monique Ingrid Andersson, Kathryn Auckland, John Kenneth Baillie, Eleanor J. Barnes, Sally Beer, Amy Beveridge, Sagida Bibi, Luke Blackwell, Martyna Borak et al. · 2020 · The Lancet Infectious Diseases
  32. The coronavirus is mutating — does it matter?
    Ewen Callaway · 2020 · Nature
  33. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
    Sandhya Bangaru, Gabriel Ozorowski, Hannah L. Turner, Aleksandar Antanasijevic, Deli Huang, Xiaoning Wang, Jonathan L. Torres, Jolene K. Diedrich, Jing-Hui Tian, Alyse D. Portnoff et al. · 2020 · Science
  34. Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
    Jimin Xu, Pei‐Yong Shi, Hongmin Li, Jia Zhou · 2020 · ACS Infectious Diseases
  35. Skin Aging, Cellular Senescence and Natural Polyphenols
    Erika Csekes, Lucia Račková · 2021 · International Journal of Molecular Sciences
  36. COVID-19 for the Cardiologist
    Deepak S. Atri, Hasan Khalid Siddiqi, Joshua P. Lang, Victor Nauffal, David A. Morrow, Erin Ann Bohula · 2020 · JACC Basic to Translational Science
  37. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
    Dapeng Li, Robert J. Edwards, Kartik Manne, David R. Martinez, Alexandra Schäfer, S. Munir Alam, Kevin J. Wiehe, Xiaozhi Lu, Robert Parks, Laura L. Sutherland et al. · 2021 · Cell
  38. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
    Tyler J. Ripperger, Jennifer L. Uhrlaub, Makiko Watanabe, Rachel Wong, Yvonne Castaneda, Hannah A. Pizzato, Mallory R. Thompson, Christine M. Bradshaw, Craig C Weinkauf, Christian Bime et al. · 2020 · Immunity
  39. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
    Jiang, He-wei, Li, Yang, Zhang, Hai-nan, Wang, Wei, Yang, Xiao, Qi, Huan, Li, Hua, Men, Dong, Zhou, Jie, Tao, Sheng-ce · 2020 · Nature Communications
  40. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy
    Marc Dinkin, Virginia Gao, Joshua Kahan, Sarah M. Bobker, Marialaura Simonetto, Paul M. Wechsler, J. Michael Harpe, Christine E. Greer, Gregory Mints, Gayle R. Salama et al. · 2020 · Neurology
  41. An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
    Leo Hanke, Laura Perez Vidakovics, Daniel J. Sheward, Hrishikesh Das, Tim Schulte, Ainhoa Moliner-Morro, Martin Corcoran, Adnane Achour, Gunilla B. Karlsson Hedestam, B. Martin Hällberg et al. · 2020 · Nature Communications
  42. Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen
    Dan Liu, Chenhui Ju, Chao Han, Rui Shi, Xuehui Chen, Demin Duan, Jinghua Yan, Xiyun Yan · 2020 · Biosensors and Bioelectronics
  43. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
    2021
  44. Proinflammatory IgG Fc structures in patients with severe COVID-19
    Chakraborty, Saborni, Gonzalez, Joseph, Edwards, Karlie, Mallajosyula, Vamsee, Buzzanco, Anthony S., Sherwood, Robert, Buffone, Cindy, Kathale, Nimish, Providenza, Susan, Xie, Markus M. et al. · 2021 · Nature Immunology
  45. Emerging treatment strategies for COVID-19 infection
    Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Eleni Korompoki, Despina Fotiou, Magdalini Migkou, Ioannis‐Georgios Tzanninis, Θεοδώρα Ψαλτοπούλου, Efstathios Kastritis, Evangelos Terpos, Meletios Athanasios Dimopoulos · 2020 · Clinical and Experimental Medicine
  46. Integrative Imaging Reveals SARS-CoV-2 Induced Reshaping of Subcellular Morphologies
    Mirko Cortese, Ji-Young Lee, Berati Cerikan, Christopher John Neufeldt, Viola M. J. Oorschot, Sebastian Köhrer, Julian Hennies, Nicole L. Schieber, Paolo Ronchi, Giulia Mizzon et al. · 2020 · Cell Host & Microbe
  47. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
    Xiangyu Chen, Ren Li, Zhiwei Pan, Chunfang Qian, Yang Yang, Renrong You, Jing Zhao, Pinghuang Liu, Leiqiong Gao, Zhirong Li et al. · 2020 · Cellular and Molecular Immunology
  48. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
    Weissman, Drew, Alameh, Mohamad-Gabriel, de Silva, Thushan, Collini, Paul, Hornsby, Hailey, Brown, Rebecca, LaBranche, Celia C., Edwards, Robert J., Sutherland, Laura, Santra, Sampa et al. · 2021 · Cell Host & Microbe
  49. Insights from nanomedicine into chloroquine efficacy against COVID-19
    Ye Hu, Matthew B. Frieman, Joy Wolfram · 2020 · Nature Nanotechnology
  50. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion
    Guido Papa, Donna L. Mallery, Anna Albecka, Lawrence G. Welch, Jérôme Cattin‐Ortolá, Jakub Lupták, David Paul, Harvey T. McMahon, Ian Goodfellow, Andrew P. Carter et al. · 2021 · PLoS Pathogens
  51. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction
    S. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Kartik Manne, Victoria Stalls, Megan Kopp, Rory C. Henderson, Robert J. Edwards et al. · 2020 · Cell Reports
  52. Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
    Xia, Xuhua · 2021 · Viruses
  53. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
    Vrishali S. Salian, Jessica A. Wright, Peter T. Vedell, Sanjana Anilkumar Nair, Chenxu Li, Mahathi Kandimalla, Xiaojia Tang, Eva M. Carmona, Krishna R. Kalari, Karunya K. Kandimalla · 2021 · Molecular Pharmaceutics
  54. Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site
    Javier A. Jaimes, Jean K. Millet, Gary R. Whittaker · 2020 · iScience
  55. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
    Jiandong Huo, Yuguang Zhao, Jingshan Ren, Daming Zhou, Helen M. E. Duyvesteyn, Helen Mary Ginn, Loïc Carrique, Tomas Malinauskas, Reinis R. Ruza, Pranav N. M. Shah et al. · 2020 · Cell Host & Microbe
  56. Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs
    David M. Kern, Ben Sorum, Sonali S. Mali, Christopher Hoel, Savitha Sridharan, Jonathan P. Remis, Daniel B. Toso, Abhay Kotecha, Diana M. Bautista, Stephen G. Brohawn · 2021 · Nature Structural & Molecular Biology
  57. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
    Yuchen Cao, Qixin Deng, Shixue Dai · 2020 · Travel Medicine and Infectious Disease
  58. A thermostable, closed SARS-CoV-2 spike protein trimer
    Xiong, Xiaoli, Qu, Kun, Ciazynska, Katarzyna A., Hosmillo, Myra, Carter, Andrew P., Ebrahimi, Soraya, Ke, Zunlong, Scheres, Sjors H. W., Bergamaschi, Laura, Grice, Guinevere L. et al. · 2020 · Nature Structural & Molecular Biology
  59. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
    Kreer, Christoph, Zehner, Matthias, Weber, Timm, Ercanoglu, Meryem S., Gieselmann, Lutz, Rohde, Cornelius, Halwe, Sandro, Korenkov, Michael, Schommers, Philipp, Vanshylla, Kanika et al. · 2020 · Cell
  60. A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
    Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, Kuldeep Dhama, Chiranjib Chakraborty · 2023 · Viruses
  61. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
    Andrea Padoan, Laura Sciacovelli, Daniela Basso, Davide Negrini, Silvia Zuin, Chiara Cosma, Diego Faggian, Paolo Maria Matricardi, Mario Plebani · 2020 · Clinica Chimica Acta
  62. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review
    Shanzay Suhail, Jonathan W. P. Zajac, Carl J. Fossum, Harrison R. Lowater, Cailin N McCracken, Nathaniel J. Severson, Bethany F. Laatsch, Alex Narkiewicz-Jodko, Benjamin Johnson, Jessica Liebau et al. · 2020 · The Protein Journal
  63. COVID-19 mRNA vaccines: Platforms and current developments
    Szabó, Gábor Tamás, Mahiny, Azita Josefine, Vlatkovic, Irena · 2022 · Molecular Therapy
  64. Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures
    Ying Yan, Le Chang, Lunan Wang · 2020 · Reviews in Medical Virology
  65. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
    Adrian Matthew Shields, Sian Elizabeth Faustini, Marisol Pérez-Toledo, Siân E. Jossi, Erin L. Aldera, Joel D. Allen, Saly Al‐Taei, Claire Backhouse, Andrew Bosworth, Lyndsey A Dunbar et al. · 2020 · Thorax
  66. Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
    Ghosh, Arun K., Brindisi, Margherita, Shahabi, Dana, Chapman, Mackenzie E., Mesecar, Andrew D. · 2020 · ChemMedChem
  67. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
    Shuai Xia, Qiaoshuai Lan, Shan Su, Xinling Wang, Wei Xu, Zezhong Liu, Yun Zhu, Qian Wang, Lu Lu, Shibo Jiang · 2020 · Signal Transduction and Targeted Therapy
  68. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
    Natalia Zamorano Cuervo, Nathalie Grandvaux · 2020 · eLife
  69. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
    Luca Perico, Ariela Benigni, Giuseppe Remuzzi · 2020 · The Nephron journals/Nephron journals
  70. Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions
    Yingjie Wang, Meiyi Liu, Jiali Gao · 2020 · Proceedings of the National Academy of Sciences
  71. Comparison of nonhuman primates identified the suitable model for COVID-19
    Shuaiyao Lu, Yuan Zhao, Wenhai Yu, Yun Yang, Jiahong Gao, Junbin Wang, Dexuan Kuang, Mengli Yang, Jing Yang, Chunxia Ma et al. · 2020 · Signal Transduction and Targeted Therapy
  72. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
    C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang, Laura M. Deveau, Thomas J. Yockachonis, Andrew S. Herbert, Michael B. Battles et al. · 2021 · Science
  73. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications
    Jean‐Pierre Changeux, Zahir Amoura, Felix Augusto Rey, Makoto Miyara · 2020 · Comptes Rendus Biologies
  74. The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device
    Alexander N. Baker, Sarah‐Jane Richards, Collette S. Guy, Thomas R. Congdon, Muhammad Hasan, Alexander J. Zwetsloot, Angelo Gallo, Józef Romuald Lewandowski, Phillip James Stansfeld, Anne Straube et al. · 2020 · ACS Central Science
  75. A materials-science perspective on tackling COVID-19
    Zhongmin Tang, Na Kong, Xingcai Zhang, Yuan Liu, Ping Hu, Shan Mou, Peter Liljeström, Jianlin Shi, Weihong Tan, Jong Seung Kim et al. · 2020 · Nature Reviews Materials
  76. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
    Evgenii Gusev, Alexey Sarapultsev, Соломатина Лилия Владимировна, В. А. Черешнев · 2022 · International Journal of Molecular Sciences
  77. Overview of lethal human coronaviruses
    Bin Chen, Er-Kang Tian, Bin He, Lejin Tian, Ruiying Han, Shuangwen Wang, Qianrong Xiang, Shu Zhang, Toufic El Arnaout, Wei Cheng · 2020 · Signal Transduction and Targeted Therapy
  78. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
    Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, Rita Kirton, Frank Kunik · 2021 · Expert Review of Clinical Pharmacology
  79. Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
    Samir Andrade Mendonça, Réka Lőrincz, Paul J. Rice-Boucher, David T. Curiel · 2021 · npj Vaccines
  80. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
    Kathryn E. Stephenson, Mathieu Le Gars, JERALD C. SADOFF, Anne Marit de Groot, Dirk Heerwegh, Carla Truyers, Caroline G. Atyeo, Carolin Loos, Abishek Chandrashekar, Katherine McMahan et al. · 2021 · JAMA
  81. A systematic review of neurological symptoms and complications of COVID-19
    Xiangliang Chen, Sarah A. Laurent, Oezguer A. Onur, Nina N. Kleineberg, Gereon R. Fink, Finja Schweitzer, Clemens Warnke · 2020 · Journal of Neurology
  82. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
    Kushal Suryamohan, Devan C. Diwanji, Eric W. Stawiski, Ravi Kr Gupta, Shane Miersch, Jiang Liu, Chao Chen, Ying-Ping Jiang, Frédéric A. Fellouse, J. Fah Sathirapongsasuti et al. · 2021 · Communications Biology
  83. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
    Yu Zheng Chen, Jinglan Wang, Chenxi Liu, Longxiang Su, Dong Zhang, Junping Fan, Yanli Yang, Meng Xiao, Jing Xie, Yingchun Xu et al. · 2020 · Molecular Medicine
  84. Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1
    Chengxin Zhang, Wei Hui Zheng, Xiaoqiang Huang, Eric W. Bell, Xiaogen Zhou, Yang Zhang · 2020 · Journal of Proteome Research
  85. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
    Eric Salazar, Katherine K. Perez, Madiha Ashraf, Jian Chen, Brian Castillo, Paul A. Christensen, Taryn A Eubank, David W. Bernard, Todd N. Eagar, Scott Wesley Long et al. · 2020 · American Journal Of Pathology
  86. A Highly Sensitive CRISPR‐Empowered Surface Plasmon Resonance Sensor for Diagnosis of Inherited Diseases with Femtomolar‐Level Real‐Time Quantification
    Fei Yan Zheng, Zhi Chen, Jingfeng Li, Rui Wu, Bin Zhang, Guohui Nie, Zhongjian Xie, Han Zhang · 2022 · Advanced Science
  87. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis
    Boun Kim Tan, Sabine Mainbourg, Arnaud Friggeri, Laurent Bertoletti, Marion Douplat, Yesim G. Dargaud, C. Grangé, Hervé Lobbes, Steeve Provencher, Jean‐Christophe Lega · 2021 · Thorax
  88. SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
    Manuel Becerra‐Flores, Timothy J. Cardozo · 2020 · International Journal of Clinical Practice
  89. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
    Ran Yu, Liang Chen, Rong Lan, Rong Shen, Peng Li · 2020 · International Journal of Antimicrobial Agents
  90. Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
    Mahesh Shanker Dhar, Robin Marwal, Radhakrishnan VS, Kalaiarasan Ponnusamy, Bani Jolly, Rahul C. Bhoyar, Viren Sardana, Salwa Naushin, Mercy Rophina, Thomas A. Mellan et al. · 2021 · Science
  91. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2
    Anshumali Mittal, Kavyashree Manjunath, Rajesh Kumar Ranjan, Sandeep Kaushik, Sujeet Kumar, Vikash Verma · 2020 · PLoS Pathogens
  92. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
    Ann‐Sofie Rudberg, Sebastian Havervall, Anna Månberg, August Jernbom Falk, Katherina Aguilera, Henry Ng, Lena Gabrielsson, Ann‐Christin Salomonsson, Leo Hanke, Ben Murrell et al. · 2020 · Nature Communications
  93. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
    Corbett, Kizzmekia S., Nason, Martha C., Flach, Britta, Gagne, Matthew, O’Connell, Sarah, Johnston, Timothy S., Shah, Shruti N., Edara, Venkata Viswanadh, Floyd, Katharine, Lai, Lilin et al. · 2021 · Science
  94. COVID-19: A review of therapeutic strategies and vaccine candidates
    Vladislav Izda, Matlock Arizona Jeffries, Amr H. Sawalha · 2020 · Clinical Immunology
  95. Antibodies to combat viral infections: development strategies and progress
    Giuseppe Pantaleo, Bruno E. Correia, Craig W. Fenwick, Victor Joo, Laurent H. Perez · 2022 · Nature Reviews Drug Discovery
  96. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
    Dong, Jinhui, Zost, Seth J., Greaney, Allison J., Starr, Tyler N., Dingens, Adam S., Chen, Elaine C., Chen, Rita E., Case, James Brett, Sutton, Rachel E., Gilchuk, Pavlo et al. · 2021 · Nature Microbiology
  97. DNA vaccines against COVID-19: Perspectives and challenges
    Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira, Marcelo Mendonça · 2020 · Life Sciences
  98. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
    Anamika Basu, Anasua Sarkar, Ujjwal Maulik · 2020 · Scientific Reports
  99. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
    Francesca Salamanna, Melania Maglio, Maria Paola Landini, Milena Fini · 2020 · Frontiers in Medicine
  100. SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
    Emily Bettini, Michela Locci · 2021 · Vaccines